1.Research Tackling Paradigm and Technological Layout Strategies Based on Erectile Dysfunction, A Clinical Dominant Disease of Traditional Chinese Medicine
Qi ZHAO ; Yun CHEN ; Baoxing LIU ; Xuejun SHANG ; Fei SUN ; Xiaozhi ZHAO ; Zhigang WU ; Chao SUN ; Peihai ZHANG ; Wanjun CHENG ; Xing ZHOU ; Zhan QIN ; Yufeng PAN ; Weiwei TAO ; Jianhuai CHEN ; Mei MO ; Xiaoxiao ZHANG ; Xing ZHANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(7):291-299
To thoroughly implement the strategic deployment outlined in the Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Inheritance and Innovative Development of Traditional Chinese Medicine regarding research on dominant diseases of traditional Chinese medicine and to uphold the development philosophy of equal emphasis on traditional Chinese medicine and western medicine,the China Association of Chinese Medicine has fully played a leading academic role by systematically organizing and conducting a series of academic youth salons on clinical dominant diseases of traditional Chinese medicine. On September 13,2024,the 36th Youth Salon on Clinical Dominant Diseases was successfully held in Nanjing,focusing on the advantages of traditional Chinese medicine and the integrative traditional Chinese medicine and western medicine in the diagnosis and treatment of erectile dysfunction (ED). The conference brought together leading experts from traditional Chinese medicine,western medicine,and interdisciplinary fields,facilitating in-depth multidisciplinary discussions that led to key consensus on optimizing traditional Chinese medicine treatment protocols for ED,researching and developing new drugs of traditional Chinese medicine,and advancing interdisciplinary development in traditional Chinese medicine. This salon systematically sorted out the clinical strengths and distinctive features of traditional Chinese medicine in the diagnosis and treatment of ED. Based on current research foundations and clinical needs,it identified key directions for future scientific layout and scientific research tackling: (1) Standardization of syndrome differentiation system of traditional Chinese medicine for ED. (2) Optimization and standardization of intervention methods of integrated traditional Chinese medicine and western medicine. (3) High-quality clinical research guided by evidence-based medicine. (4) In-depth analysis of the pharmacological mechanisms of traditional Chinese medicine in the treatment of ED. (5) Clinical translation and application promotion of new drugs of traditional Chinese medicine. (6) Interdisciplinary integration and innovation in traditional Chinese medicine. For each research direction,key focus areas,expected objectives,and clinical value were further refined,along with the establishment of a scientifically sound priority funding level evaluation system. Therefore,building on the series of salons on the ED-focused dominant diseases of traditional Chinese medicine,this paper provides standardized guidance for clinical practice of traditional Chinese medicine in ED management,effectively contributing to the high-quality development of traditional Chinese medicine. It serves as a valuable reference for national scientific and technological strategic layout, research and development decision-making in new drugs of traditional Chinese medicine,research topic planning,and clinical guideline formulation.
2.Association between takeout fast foods and sugar sweetened beverage consumption with co-occurrence of anxiety and depressive symptoms among first year junior high school students in Yunnan Province
HU Dongyue, ZHANG Zhengwu, XU Zenglei, TAO Lei, ZENG Anna, GUAN Liao, CHANG Litao,〖JZ〗 HUANG Xin, CHEN Weiwei, LI Jiangli, XU Honglü ;
Chinese Journal of School Health 2026;47(1):23-26
Objective:
To explore the association between takeout fast foods and sugar sweetened beverage consumption with co-occurrence of anxiety and depressive symptoms among first year junior high school students in Yunnan Province, so as to provide theoretical basis for the prevention of anxiety and depressive symptoms co-occurrence among adolescents.
Methods:
A random cluster sampling involving 8 500 first year junior high school students in 11 counties in Yunnan Province was conducted by a questionnaire survey from October to December 2022. The Depression Anxiety Stress Scale-21 (DASS-21) was applied to assess anxiety and depressive symptoms in first year junior high school students. Chi-square test was used to compare the anxiety-depression co-occurrence symptoms of first year junior high school students with different demographic characteristics. The association between takeout fast foods and sugar sweetened beverage consumption with co-occurrence of anxiety and depressive symptoms of adolescents was analyzed by binary Logistic regression models.
Results:
The detection rate of co-occurrence of anxiety and depression symptoms among first year junior high school students in Yunnan Province was 26.92%. After controlling for demographic variables and other confounders, takeout fast foods and sugar sweetened beverage consumption( OR=1.50, 95%CI =1.27-1.77) was associated with anxiety-depression co-occurrence symptoms among first year junior high school students in Yunnan Province ( P <0.01). Stratified analysis showed that both Han ( OR=1.37, 95%CI =1.07-1.77) and ethnic minorities ( OR=1.60, 95%CI =1.29-2.00) exhibited statistically significant associations between takeout fast foods and sugar sweetened beverage consumption with co-occurrence of anxiety and depressive symptoms(both P <0.05).
Conclusions
Takeout fast foods and sugar sweetened beverage consumption increases the risk of co-occurrence of anxiety and depressive symptoms among first year junior high school students in Yunnan Province. It is recommended to strengthen guidance on the consumption of such products among junior high school students to prevent co-occurrence of anxiety and depressive symptoms.
3.WANG Yaoxian's Experience in Treating Diabetic Kidney Disease from the Perspective of Spleen and Stomach:Based on the Theory of "Internal Heat Leading to Concretions"
Bo ZHANG ; Yuxin HU ; Cong ZHAO ; Jiale ZHANG ; Weimin JIANG ; Chang YU ; Yang LIU ; Liqiao SUN ; Weiwei SUN ;
Journal of Traditional Chinese Medicine 2026;67(5):482-486
This paper summarizes Professor WANG Yaoxian's experience in treating diabetic kidney disease (DKD) from the perspective of spleen and stomach based on the "internal heat leading to concretions" theory. It is considered that internal heat leading to concretions constitutes the core pathogenesis of DKD, with the spleen and stomach serving as the source of internal heat; therefore, treatment should be based on regulating the spleen and stomach. In the early stage of DKD, dysfunction of the spleen and stomach leads to the initial generation of internal heat. Common syndrome patterns include gastrointestinal heat accumulation and constrained heat in the liver and stomach, for which modified Gegen Qinlian Decoction (葛根芩连汤) can be used to clear heat bind while modified Dachaihu Decoction (大柴胡汤) is used to clear stomach and soothe liver, respectively. In the middle stage of DKD, weakness of the spleen and stomach results in the initial formation of concretions and conglomerations. Common patterns include spleen deficiency with prevalence of dampness and deficiency of both the spleen and kidney. Treatment emphasizes strengthening the spleen and resolving dampness, raising yang and boosting the stomach with modified Shengyang Yiwei Decoction (升阳益胃汤), or supplementing spleen and boosting kidney, dissipating bind and dispe-ring concretions with modified Shenqi Dihuang Decoction (参芪地黄汤), respectively. In the late stage of DKD, it is characterized by spleen and stomach depletion, and rampant accumulation of turbidity and toxin, and the common syndrome patterns are damp-turbidity obstruction in the middle jiao (焦) and spleen-kidney yang deficiency. Treatment aims to remove turbidity and harmonize the stomach, or to warm the kidney and strengthen the spleen while elimina-ting turbidity, using modified Dahuang Gancao Decoction(大黄甘草汤) and Jupi Zhuru Decoction (橘皮竹茹汤) or modified Baoyuan Decoction (保元汤) and Lizhong Decoction (理中汤), respectively. In clinical practice, appropriate formulas and medications are flexibly selected according to specific syndromes.
4.Exploration and effect evaluation of pharmacy practice research path for PIVAS
Hui ZHANG ; Zhou GENG ; Jingwen PU ; Weiwei LIN ; Jie PAN
China Pharmacy 2026;37(15):1943-1947
OBJECTIVE To improve the research capacity and research enthusiasm of dispensing pharmacists in pharmacy intravenous admixture services (PIVAS), facilitate their career development, and further promote the sustainable development of hospital pharmacy disciplines. METHODS A full-chain pharmacy practice research path covering topic orientation, topic evaluation, and implementation was explored and constructed for PIVAS. Multiple approaches including framework condensation for topic selection, department empowerment and improved incentive mechanisms were adopted to systematically boost the research competence and enthusiasm of PIVAS dispensing pharmacists. Four dimensions of indicators, including PIVAS research output, operational level, career development of staff and external influence, were compared between the pre-implementation period (2020- 2022) and post-implementation period (2023-2025) to evaluate the implementation effect of the path. RESULTS After the application of the PIVAS pharmacy practice research path, the number of published papers and comprehensive quality score of papers increased by 150.00% and 161.90% respectively compared with those before implementation. The number of approved research projects and comprehensive quality score of projects rose by 166.67% and 225.00%, and the number of authorized patents increased by 100.00%. The monthly number of external errors decreased from (0.42±0.18) pieces/month pre-implementation to (0.28±0.23) pieces/month post-implementation (P>0.05). Dispensing efficiency was elevated from (121.83±2.48) bags/(hour· person) to (139.00±3.46) bags/(hour·person) (P<0.05). The research participation rate of PIVAS dispensing pharmacists grew from 15.00% to 50.00%, and the overall satisfaction rate of staff increased from 55.00% to 85.00% (P<0.05). Within the 3 years after path implementation, our hospital PIVAS received a total of 22 trainees from external medical institutions, and the number of external institutional visits increased by 374.07% versus the pre-implementation stage. CONCLUSIONS The constructed pharmacy practice research path for PIVAS can significantly improve PIVAS research output, operational efficiency and external influence, and effectively promote the career growth of dispensing pharmacists working in PIVAS.
5.Correlation between nutritional status and frailty in elderly patients with cardiovascular disease
Ruolin ZHANG ; Weiwei JIANG ; Jinlin YAN ; Yongyao DU ; Lili MA
Journal of Public Health and Preventive Medicine 2026;37(5):121-125
Objective To explore the correlation between nutritional status and frailty in elderly patients with cardiovascular disease (CVD), and to provide suggestions for the prevention of frailty occurrence in elderly patients with CVD. Methods A retrospective study was conducted on 357 elderly CVD patients who were admitted to the Third Affiliated Hospital of Chengdu Medical College from May 2024 to July 2024. These patients were divided into a frailty group and a non-frailty group based on the presence or absence of frailty. Data on the patients' nutritional status indicators [body mass index (BMI), weight loss, calf circumference, albumin, and grip strength], general demographic and clinical data, laboratory and physiological indicators, and functional and activity indicators were collected. The influencing factors of frailty and the correlation between nutritional status indicators and frailty were analyzed. Results Among the 357 patients, 69 cases (19.33%) were detected with frailty, while 288 (80.67%) were without frailty. Multivariate logistic regression analysis revealed that age (OR=1.120, 95% CI: 1.023–1.225) and weight loss (OR=2.776, 95% CI: 1.145–6.732) were risk factors influencing the occurrence of frailty in elderly CVD patients (P<0.05), while grip strength (OR=0.902, 95% CI: 0.831–0.980), albumin level (OR=0.892, 95% CI: 0.806–0.988), and calf circumference (OR=0.900, 95% CI: 0.829–0.978) were protective factors of frailty occurrence in elderly CVD patients (P<0.05). Conclusion The incidence rate of frailty is relatively high in elderly patients with CVD. Age and weight loss are independent risk factors for frailty, while high grip strength level, high albumin level, and large calf circumference are independent protective factors of frailty.
6.Epidemiological characteristics of imported malaria cases in Guangxi Zhuang Autonomous Region from 2017 to 2024
Kangming LIN ; Shujiao WEI ; Jun LI ; Weiwei ZHANG ; Hui YAN ; Jun MENG
Chinese Journal of Schistosomiasis Control 2026;38(4):389-398
Objective To analyze the epidemiological characteristics of imported malaria cases in Guangxi Zhuang Autonomous Region from 2017 to 2024, so as to formulate the targeted control strategies for imported malaria. Methods The demographic and epidemiological data of malaria cases reported in Guangxi Zhuang Autonomous Region from 2017 to 2024 were collected through the China Disease Prevention and Control Information System. The source of malaria cases acquiring infections, composition of malaria parasite species, regional distribution of malaria cases, population characteristics of malaria cases, temporal distribution of malaria cases, time of diagnosis, deaths and institutions reporting malaria cases were statistically analyzed with a descriptive statistical method. Results A total of 1 308 malaria cases were reported in Guangxi Zhuang Autonomous Region from 2017 to 2024, and all cases were overseas imported cases, with no secondary cases identified. Plasmodium falciparum malaria (57.11%, 747/1 308) and P. ovale malaria (27.68%, 362/1 308) were two most common forms of malaria, and three deaths occurred among P. falciparum malaria cases. The number of malaria cases appeared an overall tendency towards a decline from 2017 to 2022, followed by a rise after 2023. The malaria cases predominantly acquired infections from Africa (1 284 cases, accounting for 98.17%), with Ghana (432 cases, accounting for 33.03%) and Cameroon (145 cases, accounting for 11.09%) as two most frequent origin countries, and P. falciparum malaria (58.02%, 745/1 284) was the predominant form of malaria among African imported malaria cases; however, P. vivax malaria cases comprised 89.58% (86/96) of all malaria cases derived from Ethiopia. In terms of regional distribution, malaria cases were highly concentrated in Nanning City (1 075 cases, accounting for 82.19%), with the most prominent situated in Shanglin County (903 cases, accounting for 69.04%), and these cases were predominantly found among individuals at ages of 20 to 59 years (1 280 cases, accounting for 97.86%), males (1 265 cases, accounting for 96.71%), and gold/coal mining workers (1 042 cases, accounting for 79.66%). In terms of temporal distribution, malaria cases were reported throughout the year, with the peak incidence in April (146 cases, accounting for 11.16%). The median duration from onset of disease to initial diagnosis was 1 (interquartile range, 2) day, and the median duration from initial diagnosis to definitive diagnosis was 1 (interquartile range, 1) day. Malaria cases were predominantly reported by medical institutions (1 075 cases, accounting for 82.19%), and the proportion of malaria cases reported by medical institutions increased from 75.92% in 2017 to 96.27% in 2024, while the proportion of malaria cases reported by disease control and prevention institutions reduced from 24.08% in 2017 to 3.73% in 2024. There was a significant difference in the proportion of malaria cases reported by medical institutions and disease control and prevention institutions from 2017 to 2024 (both P < 0.001). The 3 dead imported P. falciparum malaria cases predominantly received initial diagnosis at townshipand lower-level institutions (66.67%, 2/3), with 1 (interquartile range, 2) day median duration from onset of disease to initial diagnosis, 2 (interquartile range, 4) days median duration from initial diagnosis to definitive diagnosis, and 1 (interquartile range, 19) day median duration from definitive diagnosis to death. Conclusions Imported P. falciparum malaria from Africa is predominant among malaria cases in Guangxi Zhuang Autonomous Region, and malaria cases are highly concentrated in specific regions and among specific occupational groups. It is recommended to strengthen inter-departmental collaboration, implement refined management among labors going to Africa, improve the integration of medical treatment and disease prevention, and enhance the diagnosis and treatment of severe malaria cases.
7.Burden of chronic obstructive pulmonary disease in China from 1994 to 2023 and an age-period-cohort study
Yuan ZHANG ; Weiwei MIAO ; Liang MA ; Jianlong LI
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2026;33(10):1617-1625
Objective To systematically analyze the trend of incidence, mortality and disease burden of chronic obstructive pulmonary disease (COPD) in China from 1994 to 2023, reveal the influence of age-period-cohort factors on COPD in China and the attribution characteristics of risk factors, and provide empirical basis for formulating precise prevention and control strategies. Methods The Global Burden of Disease (GBD) 2023 database was used to extract the data of the whole population, gender and age groups of COPD in China from 1994 to 2023. The Joinpoint regression model was used to calculate the annual percentage change (APC) and average annual percentage change (AAPC) of the standardized rate. The age-period-cohort model was adopted to quantify its impacts on the incidence and mortality of COPD. It also analyzed the attributable effects as well as temporal trend characteristics of seven GBD level-3 risk factors (including smoking, ambient particulate matter pollution, occupational exposure, etc.) in Chinese population in 1994 and 2023 on the standardized mortality rate and standardized disability-adjusted life years (DALYs) rate of COPD. Results From 1994 to 2023, the incidence and mortality of COPD in China showed an upward trend, but the standardized incidence [AAPC=−1.16%, 95%CI (−1.18, −1.14), P<0.001] and standardized mortality [AAPC=−2.87%, 95%CI (−3.02, −2.73), P<0.001] decreased significantly, and the decline rate of standardized incidence in females (AAPC=−1.29%) was slightly higher than that in males (AAPC=−1.04%). The decline rate of standardized mortality in males (AAPC=−3.65%) was higher than that in females (AAPC=−1.94%). The age-period-cohort model revealed a nonlinear increase in the age effect, a graded decline in the cohort effect, and a significant period effect on mortality and male morbidity (P<0.001). In terms of attribution of risk factors, the top three attribution risks of the whole population in 2023 were still smoking, particulate matter pollution and second-hand smoke. Compared with 1994, the attribution of environmental ozone pollution, second-hand smoke, high temperature, smoking and occupational particulate matter/gas/smoke exposure increased, and the attribution of particulate matter pollution decreased. Conclusion From 1994 to 2023, the overall disease burden of COPD in China shows a downward trend. Age and cohort are the core driving factors of the disease, and period factors have a more significant impact on death. The changes in the attribution structure suggest that while consolidating the effectiveness of particulate matter pollution control, it is necessary to strengthen the comprehensive prevention and control strategies of tobacco control, coordinated emission reduction of ozone and multiple pollutants, extreme temperature protection and protection of key occupational groups, so as to continuously reduce the disease burden of COPD.
8.Interpretation and Enlightenment of Expert Consensus on Clinical Application of Yifei Zhike Capsules
Wenye FENG ; Hongchun ZHANG ; Xuefeng YU ; Weiwei GUO ; Chengjun BAN ; Zhifei WANG ; Yuanyuan LI ; Yingjie ZHI ; Jing REN ; Xin CUI ; Yanming XIE
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(23):178-185
ObjectiveTo interpret the main contents of the Expert Consensus on Clinical Application of Yifei Zhike Capsules (hereinafter referred to as the Consensus), analyze its evidence basis, and explore future research directions, thus providing a reference for rational drug use in clinical practice. MethodsThe core contents of the Consensus are summarized. Focusing on clinical issues, this paper summarizes the recommendations and consensus suggestions in the Consensus and explains them from aspects such as indications, key advantages, usage and dosage, combined medication, contraindications, precautions, and safety. ResultsThe Consensus clearly states that Yifei Zhike capsules can be used for acute or chronic bronchitis, pulmonary tuberculosis and other respiratory system diseases. It for the first time proposes that the applicable TCM syndrome of Yifei Zhike capsules is Qi-Yin deficiency together with combined phlegm and stasis. For different diseases, the Consensus provides specific usage instructions, dosage, and treatment course recommendations, supplementing the contents not covered in the drug instructions. In terms of combined medication, the Consensus emphasizes the principle of using this drug in combination with standardized chemotherapy regimens or conventional Western medicines and the applicability for the treatment of pulmonary tuberculosis and moderate to severe acute or chronic bronchitis. In terms of safety, the Consensus proposes methods for identifying common adverse reactions, drug contraindications, and precautions based on a review of the existing data and preliminarily builds a risk management framework. However, the evidence on which the Consensus is based are mostly early studies, with small sample sizes, which result in the low evidence grades (mainly C and D) of some recommendations. ConclusionThe Consensus provides specific guidance for the clinical use of Yifei Zhike capsules. However, due to the limited quality of the existing research evidence, more high-quality clinical studies are needed in the future to further verify its efficacy, safety, and explore its broader application prospects.
9.Mortality trend and prediction of chronic respiratory disease in Lianyungang City from 2011 to 2029
ZHONG Wei ; LI Weiwei ; XIANG Lu ; CHAI Lili ; DONG Jianmei ; MA Zhaojun ; QIN Xucheng ; ZHANG Weiwei
Journal of Preventive Medicine 2026;38(2):181-186
Objective:
To analyze the mortality trend of chronic respiratory diseases in Lianyungang City, Jiangsu Province from 2011 to 2024, and predict the mortality from 2025 to 2029, so as to provide the evidence for developing forward-looking prevention and control strategies and targeted intervention measures.
Methods:
Chronic respiratory disease death surveillance data in Lianyungang City from 2011 to 2024 were collected through the Jiangsu Chronic Disease Management Information Platform. The crude mortality was calculated and standardized using the data of the Sixth National Population Census in 2010. Average annual percent change (AAPC) was used to analyze the mortality trends of chronic respiratory diseases by gender, region, and age in Lianyungang City from 2011 to 2024. The GM (1,1) grey model was established using the crude mortality of chronic respiratory diseases from 2011 to 2024 to predict the crude mortality of chronic respiratory diseases from 2025 to 2029.
Results:
From 2011 to 2024, the crude mortality and standardized mortality of chronic respiratory diseases in Lianyungang City were 52.20/105 and 36.57/105, respectively. The crude mortality and standardized mortality were 53.14/105 and 43.79/105 in males, respectively, which were higher than 51.17/105 and 30.14/105 in females (both P<0.05). The crude mortality and standardized mortality were 55.62/105 and 39.85/105 in rural areas, respectively, which were higher than 38.11/105 and 24.15/105 in urban areas (both P<0.05). From 2011 to 2024, the standardized mortality of chronic respiratory diseases showed downward trends in the total population, males, females, urban areas, and rural areas (AAPC=-6.956%, -5.175%, -8.659%, -4.290%, and -7.369%, all P<0.05). The crude mortality of chronic respiratory diseases in the total population showed an upward trend with increasing age (P<0.05), reaching a peak of 1 371.20/105 in the ≥80 years group. The top two causes of chronic respiratory disease deaths were chronic obstructive pulmonary disease and bronchial asthma, with 31 792 cases and 3 254 cases, accounting for 82.40% and 8.43%, respectively. The GM (1,1) grey model prediction results showed that the crude mortality of chronic respiratory diseases in the total population from 2025 to 2029 would be 37.91/105, 36.32/105, 34.80/105, 33.34/105, and 31.95/105, respectively (average relative error=8.76%).
Conclusions
From 2011 to 2024, the mortality of chronic respiratory diseases in Lianyungang City showed a downward trend. The risk of death from chronic respiratory diseases was higher in males, rural areas, and the elderly. It is predicted that the mortality of chronic respiratory diseases will decrease year by year from 2025 to 2029.
10.Burden of disease attributable to insufficient physical activity among residents in Zhejiang Province from 1990 to 2021
ZHANG Jie ; ZHOU Xiaoyan ; HU Ruying ; GONG Weiwei ; PAN Jin ; ZHONG Jieming
Journal of Preventive Medicine 2026;38(3):251-256
Objective:
To analyze the trend in disease burden attributable to insufficient physical activity among residents in Zhejiang Province from 1990 to 2021, so as to provide evidence for developing targeted prevention and control strategies.
Methods:
Data on years of life lost due to premature mortality (YLL), years lived with disability (YLD), and disability-adjusted life years (DALY) due to insufficient physical activity among residents of Zhejiang Province were collected from the Global Burden of Disease (GBD) 2021 database. The average annual percentage change was used to analyze the trends in YLL, YLD, and DALY rates from 1990 to 2021.
Results:
YLL, YLD, and DALY rates attributable to insufficient physical activity among residents of Zhejiang Province increased from 42.65/105, 11.12/105, and 53.77/105 in 1990 to 85.67/105, 31.56/105, and 117.23/105 in 2021, respectively, showing an upward trend (AAPC=2.267%, 3.428%, and 2.517%, all P<0.05). From 1990 to 2021, the YLL, YLD, and DALY rates attributable to insufficient physical activity were consistently higher in females than in males. Both males and females demonstrated upward trends in YLL (AAPC=2.631%, 2.031%), YLD (AAPC=3.711%, 3.268%), and DALY (AAPC=2.840%, 2.303%) rates (all P<0.05). From 1990 to 2021, the YLL, YLD, and DALY rates were highest in the ≥70 years age group. From 1990 to 2021, 15-<50 and ≥70 years age groups showed upward trends in YLL (AAPC=0.439%, 0.818%), YLD (AAPC=3.102%, 1.351%), and DALY (AAPC=1.749%, 0.932%) rates (all P<0.05). The 50-<70 years age group exhibited an increasing trend in YLD rate (AAPC=1.222%), while declining trends in YLL (AAPC=-1.400%) and DALY (AAPC=-0.663%) (all P<0.05). In both 1990 and 2021, the top five diseases attributable to insufficient physical activity in Zhejiang Province were stroke, diabetes, colorectal cancer, ischemic heart disease, and chronic kidney disease. Compared to 1990, the DALY rates for these five diseases increased in 2021, with change rates of 89.20%, 164.84%, 110.67%, 223.40%, and 80.95%, respectively.
Conclusions
From 1990 to 2021, the overall disease burden attributable to insufficient physical activity in Zhejiang Province showed an upward trend. The disease burden was relatively high among females, the elderly, and for chronic diseases such as stroke, while premature mortality burden declined among residents aged 50-<70 years.


Result Analysis
Print
Save
E-mail